AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- 52-wk high
- $32.71
- 52-wk low
- $8.80
- Prev close
- $19.63
- Mkt cap
- $900.2M
- P/S
- 7.6x
- P/B
- 3.3x
Smart money
Earnings
Earnings came in 14.5% above what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $27.3M | $32.1M | $27.6M | $32.0M |
| Cost of what it sold | $12.1M | $13.2M | $11.2M | $13.1M |
| Gross profit | $15.1M | $18.9M | $16.4M | $18.9M |
| What it spent | ||||
| Research and development | $8.2M | $10.1M | $10.4M | $10.2M |
| Sales and admin | $7.9M | $8.6M | $9.6M | $9.6M |
| Other operating costs | $16.0M | $16.3M | $20.7M | $24.6M |
| Total operating expenses | $32.2M | $35.1M | $40.7M | $44.5M |
| What was left | ||||
| Operating profit | -$17.0M | -$16.1M | -$24.3M | -$25.6M |
| Profit before tax | -$14.2M | -$13.5M | -$21.9M | -$23.4M |
| Tax | — | $1.0K | — | — |
| Net profit | -$14.2M | -$13.5M | -$21.9M | -$23.4M |
| EBITDA | -$13.5M | -$12.5M | -$21.2M | -$24.5M |
Technicals
Price structure
No data yet
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
5 articles · 7 days
Coverage is bullish
Tone of tracked coverage
Farallon group discloses 595,000-share Beta Bionics (BBNX) stake in 13G/A
NeutralAug 13BofA Securities Maintains Beta Bionics(BBNX.US) With Hold Rating, Raises Target Price to $18
Leans bullishAug 12Beta Bionics, Inc. Stock 12‑Month Price Target Raised to $20.31, Implies 24% Upside
BullishAug 11
